Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2022

Open Access 01-12-2022 | Spirometry | Research

Normal spirometry prediction equations for the Iranian population

Authors: Leyla Sahebi, Besharat Rahimi, Mamak Shariat, Seyyed Hosein Mousavy, Mohsen Hosseini

Published in: BMC Pulmonary Medicine | Issue 1/2022

Login to get access

Abstract

Background

This study aimed to establish normative spirometric equations in a healthy population of Iranian children and adults, and compare these equations with those developed by the Caucasian Global Lung Initiative (GLI) for the first time.

Methods

Spirometric data from healthy Iranian aged 4–82 years sampled in 2019 were used to derive reference equations using the generalized additive model for location (mu), shape (lambda), and scale (sigma).

Results

A total of 418 females and 204 males were included in the study. Applying the GLI standards for the Iranian population resulted from the Z scores of FEV1, FVC, FEV1/FVC, and FEF25−75% was not different from zero. Based on the newly calculated LLN, eleven individuals showed significant values below the LLN for FEV1/FVC. In all age groups, this frequency was less than 5%, except for men over 70 years of age, which was 12.5%. There are significant differences between new data and GLI for Caucasian data.

Conclusion

It is recommended that the values and equations generated from this study should be used by physicians and technicians in their routine practice for the diagnosis and assessment of pulmonary disorders.
Appendix
Available only for authorised users
Literature
4.
go back to reference Yang TS, Peat J, Keena V, Donnelly P, Unger W, Woolcock A. A review of the racial differences in the lung function of normal Caucasian, Chinese and Indian subjects. Eur Respir J. 1991;4(7):872–80.CrossRef Yang TS, Peat J, Keena V, Donnelly P, Unger W, Woolcock A. A review of the racial differences in the lung function of normal Caucasian, Chinese and Indian subjects. Eur Respir J. 1991;4(7):872–80.CrossRef
6.
go back to reference Blake TL, Chang AB, Chatfield MD, Marchant JM, McElrea MS. Global lung function Initiative-2012 ‘other/mixed’ spirometry reference equation provides the best overall fit for Australian Aboriginal and/or Torres Strait Islander children and young adults. Respirology (Carlton Vic). 2020;25(3):281–8. https://doi.org/10.1111/resp.13649.CrossRef Blake TL, Chang AB, Chatfield MD, Marchant JM, McElrea MS. Global lung function Initiative-2012 ‘other/mixed’ spirometry reference equation provides the best overall fit for Australian Aboriginal and/or Torres Strait Islander children and young adults. Respirology (Carlton Vic). 2020;25(3):281–8. https://​doi.​org/​10.​1111/​resp.​13649.CrossRef
23.
go back to reference Quanjer PHSS, Stocks J, Cole TJ, Stocks J. GAMLSS in action, 2012. Quanjer PHSS, Stocks J, Cole TJ, Stocks J. GAMLSS in action, 2012.
Metadata
Title
Normal spirometry prediction equations for the Iranian population
Authors
Leyla Sahebi
Besharat Rahimi
Mamak Shariat
Seyyed Hosein Mousavy
Mohsen Hosseini
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Spirometry
Published in
BMC Pulmonary Medicine / Issue 1/2022
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-022-02273-8

Other articles of this Issue 1/2022

BMC Pulmonary Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.